01 / Decision point
Company state
Founder-led, early-stage, and pre-revenue unless supported by signed documentary evidence.
Investor overview / Milestone-gated frontier technology
One commercial wedge. Six compounding programs.
Planckchron is building an evidence-led operating architecture for consequential AI and frontier systems. HERA Nexus is the near-term commercial entry point; Aetherion Core, BioForge + GenovaX, Helios Autonomy, EchoNet, and PX-Phantom remain independently gated programs within the portfolio.
HERA NexusNear-term commercial wedge
Six programsNo product removed; every program has an evidence gate
18 monthsDefined de-risking and paid-pilot conversion sequence
Pre-revenueNo established revenue represented without evidence
Investor decision brief / July 2026
The company in one diligence-ready view.
02 / Decision point
Commercial wedge
HERA Nexus: a human-supervised intelligence layer for consequential, evidence-heavy workflows.
03 / Decision point
Portfolio model
Six retained programs governed by three operating horizons and explicit evidence gates.
04 / Decision point
18-month objective
Move from a bounded workflow and prototype to controlled external evaluation and a credible paid-pilot path.
05 / Decision point
Financing discipline
Round size, security, valuation, capitalization, runway, and detailed budget remain subject to qualified diligence and definitive documents.
06 / Decision point
Public evidence boundary
No undisclosed revenue, customer, benchmark, patent, certification, partnership, staffing, or financing result is represented as validated.
This public brief is informational only. It is not an offer to sell securities, a solicitation, a projection of guaranteed outcomes, or a substitute for legal, financial, technical, commercial, capitalization, intellectual-property, regulatory, and conflict diligence.
Investment thesis
The portfolio is broad. The operating model is concentrated.
One operating architecture, one near-term commercial wedge, and five milestone-gated proving grounds.
01
A platform thesis with a focused entry point
Planckchron is not financing six independent startups. HERA Nexus is the near-term commercial wedge; the remaining programs are milestone-gated proving grounds for a shared intelligence, evidence, governance, and human-authority architecture.
02
Consequence creates demand for accountability
Organizations operating regulated, evidence-heavy, or safety-sensitive workflows need traceable decisions, explicit permissions, intervention boundaries, and accountable human ownership.
03
Capital follows evidence
Programs advance only when a technical, customer, governance, or economic uncertainty is materially reduced. The portfolio remains intact, but capital concentration is earned rather than assumed.
Portfolio sequencing
Every product stays. Every dollar has an order.
Program maturity and capital priority are not the same thing. HERA receives near-term commercial concentration; adjacent and long-horizon programs advance through explicit evidence gates.
01 / Commercial wedgeResearch
HERA Nexus
Artificial intelligence. Validate one human-supervised intelligence workflow with a design partner and measurable operating outcomes.
Next gate: Working prototype, named workflow owner, baseline measurement, and external review.
Review program
02 / Adjacent validationPrototype
EchoNet
Resilient communications. Demonstrate bounded coordination and graceful degradation in a controlled network environment.
Next gate: Documented test method, network conditions, repeatable results, and failure analysis.
Review program
03 / Adjacent validationDesign & Prototype
Helios Autonomy
Autonomous systems. Test accountable perception, planning, escalation, and human intervention boundaries in simulation.
Next gate: Scenario suite, intervention criteria, recorded decisions, and independent technical review.
Review program
04 / Long-horizon R&DDesign & Prototype
Aetherion Core
Emerging compute. Define and test the most consequential assumptions in the post-silicon and hybrid compute architecture.
Next gate: Published architecture note, simulation method, reproducible model, and clearly labeled limitations.
Review program
05 / Long-horizon R&DResearch
BioForge + GenovaX
Biotechnology. Develop evidence-aware research workflows and identify one bounded biotechnology use case for external review.
Next gate: Defined research question, responsible-review process, reproducible workflow, and qualified domain partner.
Review program
06 / Long-horizon R&DDesign & Prototype
PX-Phantom
Aerospace systems. Convert the aerospace thesis into a simulation-led research program with explicit engineering constraints.
Next gate: Requirements baseline, simulation assumptions, engineering review, and dated test plan.
Review program
Commercial entry point
Start where evidence, authority, and AI collide.
Organizations operating consequential, evidence-heavy workflows that require human authority, reviewable decisions, and stronger accountability than general-purpose AI tools provide.
01
Why now?
AI adoption is moving faster than institutional mechanisms for review, evidence, authority, and accountability.
02
Why this team?
The company is founder-led and building a focused technical core supported by qualified domain review and documented relationships.
03
What is the first market?
Organizations operating consequential, evidence-heavy workflows that require human authority, reviewable decisions, and stronger accountability than general-purpose AI tools provide.
04
What must be proven next?
A bounded HERA workflow must demonstrate measurable value, retained external use, and a credible path to paid pilot activity.
18-month operating plan
Capital buys decisions—not optics.
The plan moves from a defined customer problem to a bounded prototype, controlled external evaluation, and paid-pilot conversion path.
0–3 months
Freeze the HERA v1 problem definition, customer profile, technical architecture, security boundary, and measurement plan.
Proceed only with a named accountable workflow and an external design-partner signal.4–6 months
Deliver a bounded HERA prototype with evidence capture, human approval, intervention controls, and audit history.
Proceed only if the prototype reduces a measurable workflow failure or operating burden.7–12 months
Run controlled design-partner evaluations and publish dated evidence records for the primary workflow.
Proceed only with retained use, credible user pull, and a defined path to a paid pilot.13–18 months
Convert validated use into paid pilot activity while advancing one EchoNet or Helios adjacent validation program.
Scale headcount and capital only when technical evidence, governance, and economics support expansion.Illustrative use of proceeds
Concentrate capital where uncertainty can be reduced.
Final round size, security, ownership impact, runway assumptions, and line-item budget must reconcile to the capitalization table and approved operating plan during qualified diligence.
| Allocation | Priority | Required output |
|---|---|---|
| 45% | Core product and engineering | HERA prototype, security architecture, evidence system, and production-quality technical foundation. |
| 20% | Design partnerships and validation | External workflow definition, controlled evaluations, user evidence, and paid-pilot conversion path. |
| 15% | Technical talent and domain review | Full-time engineering capacity plus qualified independent review for high-consequence technical claims. |
| 10% | Security, governance, and compliance | Access controls, privacy practices, review boundaries, risk acceptance, and diligence-ready records. |
| 10% | Focused operations and runway | Legal, finance, recruiting, program management, and operating cadence tied to approved milestones. |
Qualified diligence
A serious conversation starts with documents.
Qualified investors should test ownership, technical evidence, operating assumptions, commercial signals, intellectual property, disclosed relationships, conflicts, and legal readiness.
01
Corporate formation, capitalization, ownership, and material agreements
02
18-month operating plan, milestone budget, hiring plan, runway, and financing structure
03
Product architecture, security model, technical assumptions, and evidence records
04
Design-partner pipeline, customer discovery, pilot criteria, and commercial model
05
Intellectual-property inventory, contributor assignments, and third-party dependency review
06
Advisor appointment documentation, role scope, disclosure consent, and conflict review
Diligence access
Qualify the investor before opening the data room.
The public site provides the thesis and evidence boundaries. Non-public materials are released selectively after investment-fit, identity, conflict, confidentiality, and legal review.
Access sequence
What happens after submission
- 01 — Qualification. Confirm firm, role, mandate, strategic fit, and likely financing pathway.
- 02 — Conflict and confidentiality. Determine whether an NDA or other access terms are appropriate.
- 03 — Scoped release. Share only materials relevant to the approved diligence stage.
- 04 — Management review. Resolve technical, commercial, capitalization, governance, and risk questions.
Material uncertainty
The risks are part of the investment case.
This public summary is not an offer to sell securities and is not a substitute for complete legal, technical, financial, capitalization, commercial, intellectual-property, conflict, and regulatory diligence.
01
Technical
The architecture or individual programs may not achieve intended performance, reliability, integration, or safety.
02
Focus
Management must protect the HERA commercial wedge from long-horizon distraction and apply explicit capital gates.
03
Commercial
Design-partner interest may not convert into paid pilots, repeatable demand, or durable revenue.
04
Team
Planckchron must recruit full-time engineering, product, security, and domain leadership appropriate to each approved milestone.
05
Capital
Frontier programs may require more financing than anticipated, creating dilution and sequencing risk.
06
Regulatory
AI, biotechnology, autonomy, aerospace, privacy, and security requirements may change across jurisdictions.
Investor briefing
Evaluate the company as it is—and the milestones disciplined capital can unlock.
Review the evidence registry first, then request scoped access for capitalization, budget, technical, commercial, intellectual-property, governance, and risk diligence.